Biomarkers for In Vivo Assessment of Transporter Function

No abstract is available for this paper.

• Publication year

  2018

• Venue

  Pharmacological Reviews

• Publication date

  2018-04-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1124/pr.116.013326PMID 29487084
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Endogenous Probes for Drug Transporters: Balancing Vision With Reality

  2018cited by this paper
• Coproporphyrin-I: A Fluorescent, Endogenous Optimal Probe Substrate for ABCC2 (MRP2) Suitable for Vesicle-Based MRP2 Inhibition Assay

  2017influential reference
• Serum N 1‐Methylnicotinamide is Associated With Coronary Artery Disease in Chinese Patients

  2017cited by this paper
• Effects of Metformin and Furosemide on Rosuvastatin Pharmacokinetics in Healthy Volunteers: Implications for Their Use as Probe Drugs in a Transporter Cocktail

  2017cited by this paper
• Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporters and CYP3A

  2017influential reference
• Leveraging of Rifampicin-Dosed Cynomolgus Monkeys to Identify Bile Acid 3-O-Sulfate Conjugates as Potential Novel Biomarkers for Organic Anion-Transporting Polypeptides

  2017cited by this paper
• Comparative Evaluation of Plasma Bile Acids, Dehydroepiandrosterone Sulfate, Hexadecanedioate, and Tetradecanedioate with Coproporphyrins I and III as Markers of OATP Inhibition in Healthy Subjects

  2017influential reference
• Comparative Evaluation of Dehydroepiandrosterone Sulfate Potential to Predict Hepatic Organic Anion Transporting Polypeptide Transporter-Based Drug-Drug Interactions

  2017influential reference
• Organic Anion Transporter 2: An Enigmatic Human Solute Carrier

  2017influential reference
• Evaluation of Renal Transporter Inhibition Using Creatinine as a Substrate In Vitro to Assess the Clinical Risk of Elevated Serum Creatinine.

  2017influential reference
• Identification of Endogenous Biomarkers to Predict the Propensity of Drug Candidates to Cause Hepatic or Renal Transporter-Mediated Drug-Drug Interactions.

  2017cited by this paper
• Variants in Pharmacokinetic Transporters and Glycemic Response to Metformin: A Metgen Meta‐Analysis

  2017cited by this paper
• Investigation of Glycochenodeoxycholate Sulfate and Chenodeoxycholate Glucuronide as Surrogate Endogenous Probes for Drug Interaction Studies of OATP1B1 and OATP1B3 in Healthy Japanese Volunteers

  2017influential reference
• Pregnancy Increases the Renal Secretion of N1-methylnicotinamide, an Endogenous Probe for Renal Cation Transporters, in Patients Prescribed Metformin

  2017cited by this paper
• Preference of Conjugated Bile Acids over Unconjugated Bile Acids as Substrates for OATP1B1 and OATP1B3

  2017influential reference
• A Rapid and Efficient Assay for the Characterization of Substrates and Inhibitors of Nicotinamide N-Methyltransferase.

  2016cited by this paper
• Urinary Dopamine as a Potential Index of the Transport Activity of Multidrug and Toxin Extrusion in the Kidney

  2016influential reference
• Comparing Various In Vitro Prediction Criteria to Assess the Potential of a New Molecular Entity to Inhibit Organic Anion Transporting Polypeptide 1B1

  2016cited by this paper
• Metabolomic and Genome‐wide Association Studies Reveal Potential Endogenous Biomarkers for OATP1B1

  2016cited by this paper
• The Effect of Dolutegravir on the Pharmacokinetics of Metformin in Healthy Subjects

  2016cited by this paper
• Activation of the nicotinamide N-methyltransferase (NNMT)-1-methylnicotinamide (MNA) pathway in pulmonary hypertension

  2016cited by this paper
• Effect of Diet on Serum Creatinine in Healthy Subjects During a Phase I Study

  2016cited by this paper
• Post-translational modification by acetylation regulates the mitochondrial carnitine/acylcarnitine transport protein

  2016cited by this paper
• Carboxy-terminal mutations of bile acid CoA:N-acyltransferase alter activity and substrate specificity

  2016cited by this paper
• Structure and function of multidrug and toxin extrusion proteins (MATEs) and their relevance to drug therapy and personalized medicine

  2016influential reference
• Loss-of-function variants influence the human serum metabolome

  2016cited by this paper
• Identification of sex-specific urinary biomarkers for major depressive disorder by combined application of NMR- and GC–MS-based metabonomics

  2016cited by this paper
• Microdosing and Other Phase 0 Clinical Trials: Facilitating Translation in Drug Development

  2016cited by this paper
• Investigation of Endogenous Compounds Applicable to Drug–Drug Interaction Studies Involving the Renal Organic Anion Transporters, OAT1 and OAT3, in Humans

  2016influential reference
• Higher diet-dependent renal acid load associates with higher glucocorticoid secretion and potentially bioactive free glucocorticoids in healthy children.

  2016cited by this paper
• Clinical, Biochemical and Molecular Characteristics of the Main Types of Porphyria.

  2016cited by this paper
• Nutritional Stress Induced by Tryptophan-Degrading Enzymes Results in ATF4-Dependent Reprogramming of the Amino Acid Transporter Profile in Tumor Cells.

  2016cited by this paper
• Inhibition of the multidrug and toxin extrusion (MATE) transporter by pyrimethamine increases the plasma concentration of metformin but does not increase antihyperglycaemic activity in humans

  2016cited by this paper
• The Complexities of Interpreting Reversible Elevated Serum Creatinine Levels in Drug Development: Does a Correlation with Inhibition of Renal Transporters Exist?

  2016influential reference
• Pharmacokinetic Evaluation of a Drug Transporter Cocktail Consisting of Digoxin, Furosemide, Metformin, and Rosuvastatin

  2016influential reference
• Coproporphyrins in Plasma and Urine Can Be Appropriate Clinical Biomarkers to Recapitulate Drug-Drug Interactions Mediated by Organic Anion Transporting Polypeptide Inhibition

  2016cited by this paper
• Coproporphyrins I and III as Functional Markers of OATP1B Activity: In Vitro and In Vivo Evaluation in Preclinical Species

  2016influential reference
• Predicting transporter‐mediated drug interactions: Commentary on: “Pharmacokinetic evaluation of a drug transporter cocktail consisting of digoxin, furosemide, metformin and rosuvastatin” and “Validation of a microdose probe drug cocktail for clinical drug interaction assessments for drug transporte

  2016cited by this paper
• Organic anion transporting polypeptide (OATP)-mediated transport of coproporphyrins I and III

  2016influential reference
• Approaching complete inhibition of P-glycoprotein at the human blood–brain barrier: an (R)-[11C]verapamil PET study

  2015cited by this paper
• Utility of Bilirubins and Bile Acids as Endogenous Biomarkers for the Inhibition of Hepatic Transporters

  2015influential reference
• Association of nicotinamide-N-methyltransferase mRNA expression in human adipose tissue and the plasma concentration of its product, 1-methylnicotinamide, with insulin resistance

  2015cited by this paper
• A GWAS Study on Liver Function Test Using eMERGE Network Participants

  2015cited by this paper
• Evaluation of Cynomolgus Monkeys for the Identification of Endogenous Biomarkers for Hepatic Transporter Inhibition and as a Translatable Model to Predict Pharmacokinetic Interactions with Statins in Humans

  2015cited by this paper
• Role of organic cation transporters in drug–drug interaction

  2015cited by this paper
• Involvement of Organic Cation Transporters in the Clearance and Milk Secretion of Thiamine in Mice

  2015influential reference
• Dehydroepiandrosterone sulfate, a useful endogenous probe for evaluation of drug-drug interaction on hepatic organic anion transporting polypeptide (OATP) in cynomolgus monkeys.

  2015influential reference
• Carnitine transporter CT2 (SLC22A16) is over-expressed in acute myeloid leukemia (AML) and target knockdown reduces growth and viability of AML cells

  2015cited by this paper
• Quantitative bile acid profiling by liquid chromatography quadrupole time-of-flight mass spectrometry: monitoring hepatitis B therapy by a novel Na+-taurocholate cotransporting polypeptide inhibitor

  2015influential reference
• Metabolomic Identification of a Novel Pathway of Blood Pressure Regulation Involving Hexadecanedioate

  2015cited by this paper
• Characterization of Organic Anion Transporter 2 (SLC22A7): A Highly Efficient Transporter for Creatinine and Species-Dependent Renal Tubular Expression

  2015influential reference
• Urinary bile acids as biomarkers for liver diseases I. Stability of the baseline profile in healthy subjects.

  2015influential reference
• The Use of Transporter Probe Drug Cocktails for the Assessment of Transporter-Based Drug-Drug Interactions in a Clinical Setting-Proposal of a Four Component Transporter Cocktail.

  2015influential reference
• Urinary bile acids as biomarkers for liver diseases II. Signature profiles in patients.

  2015influential reference
• Physiological role of taurine – from organism to organelle

  2015influential reference
• PET Tracers To Study Clinically Relevant Hepatic Transporters.

  2015cited by this paper
• Serum N(1)-Methylnicotinamide Is Associated With Obesity and Diabetes in Chinese.

  2015cited by this paper
• Taurine in 24-h Urine Samples Is Inversely Related to Cardiovascular Risks of Middle Aged Subjects in 50 Populations of the World.

  2015cited by this paper
• Regulation of the Dopamine and Vesicular Monoamine Transporters: Pharmacological Targets and Implications for Disease

  2015cited by this paper
• Beriberi, a Severe Complication after Metabolic Surgery – Review of the Literature

  2014cited by this paper
• GFR estimation: from physiology to public health.

  2014cited by this paper
• 6β-Hydroxycortisol Is an Endogenous Probe for Evaluation of Drug–Drug Interactions Involving a Multispecific Renal Organic Anion Transporter, OAT3/SLC22A8, in Healthy Subjects

  2014influential reference
• Palliative treatment of thiamine-related encephalopathy (Wernicke's encephalopathy) in cancer: A case series and review of the literature

  2014cited by this paper
• Rare mutations associating with serum creatinine and chronic kidney disease.

  2014cited by this paper
• Thiamin function, metabolism, uptake, and transport.

  2014cited by this paper
• Contribution of the organic anion transporter OAT2 to the renal active tubular secretion of creatinine and mechanism for serum creatinine elevations caused by cobicistat

  2014influential reference
• Validation of 4β-hydroxycholesterol and evaluation of other endogenous biomarkers for the assessment of CYP3A activity in healthy subjects.

  2014cited by this paper
• What do drug transporters really do?

  2014cited by this paper
• Using Positron Emission Tomography to Study Transporter-Mediated Drug–Drug Interactions in Tissues

  2014influential reference
• OCT1 is a high-capacity thiamine transporter that regulates hepatic steatosis and is a target of metformin

  2014influential reference
• Thiamine in the treatment of Wernicke encephalopathy in patients with alcohol use disorders

  2014cited by this paper
• PET imaging of Oatp-mediated hepatobiliary transport of [(11)C] rosuvastatin in the rat.

  2014influential reference
• Defects of thiamine transport and metabolism

  2014cited by this paper
• How the use of creatine supplements can elevate serum creatinine in the absence of underlying kidney pathology

  2014cited by this paper
• An atlas of genetic influences on human blood metabolites

  2014influential reference
• Common Drugs Inhibit Human Organic Cation Transporter 1 (OCT1)-Mediated Neurotransmitter Uptake

  2014cited by this paper
• The Roles of MRP2, MRP3, OATP1B1, and OATP1B3 in Conjugated Hyperbilirubinemia

  2014influential reference
• Simultaneous determination of N(1)-methylnicotinamide, L-carnitine, and creatinine in human plasma and urine by liquid chromatography with mass spectrometry for assessing the activities of multiple renal cationic transporters.

  2014cited by this paper
• Genetic implication of a novel thiamine transporter in human hypertension.

  2014cited by this paper
• Measuring GFR: a systematic review.

  2014cited by this paper
• Time-dependent effects of L-tryptophan administration on urinary excretion of L-tryptophan metabolites.

  2014influential reference
• N1-methylnicotinamide as an endogenous probe for drug interactions by renal cation transporters: studies on the metformin–trimethoprim interaction

  2014influential reference
• Effect of a Cooked Meat Meal on Serum Creatinine and Estimated Glomerular Filtration Rate in Diabetes-Related Kidney Disease

  2014cited by this paper
• Pitavastatin is a more sensitive and selective organic anion-transporting polypeptide 1B clinical probe than rosuvastatin.

  2014cited by this paper
• Assessment of Vandetanib as an Inhibitor of Various Human Renal Transporters: Inhibition of Multidrug and Toxin Extrusion as a Possible Mechanism Leading to Decreased Cisplatin and Creatinine Clearance

  2013cited by this paper
• Investigation of Endogenous Compounds for Assessing the Drug Interactions in the Urinary Excretion Involving Multidrug and Toxin Extrusion Proteins

  2013influential reference
• SLC18: Vesicular neurotransmitter transporters for monoamines and acetylcholine.

  2013cited by this paper
• Transporter Studies in Drug Development: Experience to Date and Follow‐Up on Decision Trees From the International Transporter Consortium

  2013cited by this paper
• Folate and thiamine transporters mediated by facilitative carriers (SLC19A1-3 and SLC46A1) and folate receptors.

  2013cited by this paper
• SLC22A2 is associated with tubular creatinine secretion and bias of estimated GFR in renal transplantation.

  2013cited by this paper
• Intraindividual and Interindividual Variabilities in Endogenous Cortisol 6β-Hydroxylation Clearance as an Index for In Vivo CYP3A Phenotyping in Humans

  2013cited by this paper
• A phase 1 study to evaluate the effect of dolutegravir on renal function via measurement of iohexol and para-aminohippurate clearance in healthy subjects.

  2013cited by this paper
• The mitochondrial transporter family SLC25: identification, properties and physiopathology.

  2013cited by this paper
• Emerging Transporters of Clinical Importance: An Update From the International Transporter Consortium

  2013influential reference
• Absence of effect of SLC22A2 genotype on cisplatin‐induced nephrotoxicity in oesophageal cancer patients receiving cisplatin and 5‐fluorouracil: report of results discordant with those of earlier studies

  2013cited by this paper
• The profile of bile acids and their sulfate metabolites in human urine and serum.

  2013influential reference
• A Genome‐Wide Association Study for Serum Bilirubin Levels and Gene‐Environment Interaction in a Chinese Population

  2013influential reference
• Transporters and Drug-Drug Interactions: Important Determinants of Drug Disposition and Effects

  2013cited by this paper
• Drug–Drug Interaction Studies: Regulatory Guidance and An Industry Perspective

  2013cited by this paper
• Effect of the Fluoroquinolone Antibacterial Agent DX-619 on the Apparent Formation and Renal Clearances of 6β-Hydroxycortisol, an Endogenous Probe for CYP3A4 Inhibition, in Healthy Subjects

  2013influential reference

• The Causal Relationship between Lipid Metabolites and Multiple Myeloma Risk: A Mendelian Randomization Study.

  2025cites this paper
• Putative new biomarkers for renal transporter-mediated drug-drug interactions: Characterization as substrates of organic cation transporter 2, multidrug and toxin extrusion protein 1, and other important drug transporters

  2025cites this paper
• Dissecting Causal Relationships Between Immune Cells, Plasma Metabolites, and PCOS: Evidence From Mediating Mendelian Randomization Analysis

  2025cites this paper
• Recent advances in mass spectrometry-based bioanalytical methods for endogenous biomarkers analysis in transporter-mediated drug-drug interactions

  2025cites this paper
• In vitro transporter substrate properties of previously reported biomarkers for renal OAT1/OAT3-mediated drug-drug interactions.

  2025cites this paper
• Integrative multiomics elucidate crotonylation-associated GCDH in Parkinson’s disease pathogenesis via metabolome remodeling

  2025influential citation
• Evaluating the utility of endogenous OCT2 and MATE1/2-K biomarkers for DDI assessment in early clinical settings.

  2025cites this paper
• Predicting OCT2/MATEs‐Mediated Drug Interactions in Healthy Volunteers and Patients with Chronic Kidney Disease: Insights from Extended Clearance Concept, Endogenous Biomarkers, and In Vitro Inhibition Studies (Perspectives from the International Transporter Consortium)

  2025cites this paper
• Blood Metabolome Mediates the Effect of the Plasma Lipidome on the Risk of Atrial Fibrillation: A Mendelian Randomization Study

  2025cites this paper
• Precision medication based on the evaluation of drug metabolizing enzyme and transporter functions

  2025cites this paper
• Is N1-Methylnicotinamide a Good Organic Cation Transporter 2 (OCT2) Biomarker?

  2025cites this paper
• Organic cation transporters 2: Structure, regulation, functions, and clinical implications.

  2025cites this paper
• Clinical Assessment of Drug Transporter Inhibition Using Biomarkers: Review of the Literature (2015‐2024)

  2025cites this paper
• Impact of 1α,25-dihydroxyvitamin D_3 on biodistribution and pharmacokinetics of L-carnitine and creatinine, organic cation/carnitine transporter 2 and organic cation transporter 2 biomarkers

  2024cites this paper
• Non‐targeted metabolomics for the identification of plasma metabolites associated with organic anion transporting polypeptide 1B1 function

  2024cites this paper
• A Pilot Study To Assess the Suitability of Riboflavin As a Surrogate Marker of Breast Cancer Resistance Protein in Healthy Participants

  2024cites this paper
• Organic anion transporting polypeptides: Pharmacology, toxicology, structure, and transport mechanisms.

  2024cites this paper
• Effects of Cimetidine and Dolutegravir on the Endogenous Drug–Drug Interaction Biomarkers for Organic Cation Transporter 2 and Multidrug and Toxin Extrusion Protein 1 in Healthy Volunteers

  2024cites this paper
• Plasma and urinary CP I and CP III concentrations in chimeric mice with human hepatocytes after rifampicin administration

  2024cites this paper
• The toxicity of cisplatin derives from effects on renal organic ion transporters expression and serum endogenous substance levels.

  2024cites this paper
• New Biomarkers for Renal Transporter‐Mediated Drug–Drug Interactions: Metabolomic Effects of Cimetidine, Probenecid, Verapamil, and Rifampin in Humans

  2024cites this paper
• Ticagrelor modestly raises plasma riboflavin concentration in humans and inhibits riboflavin transport by BCRP and MRP4

  2024cites this paper
• Genetic insights of blood lipid metabolites on polycystic ovary syndrome risk: a bidirectional two-sample Mendelian randomization study

  2024influential citation
• Pseudo‐Worsening of Kidney Function Due to Inhibition of Renal Creatinine Secretion: Quality of Information Provided in Prescribing Information/SmPC

  2024cites this paper
• Utilising Endogenous Biomarkers in Drug Development to Streamline the Assessment of Drug–Drug Interactions Mediated by Renal Transporters: A Pharmaceutical Industry Perspective

  2024cites this paper
• Exploring the causal association between genetically determined circulating metabolome and hemorrhagic stroke

  2024cites this paper
• An Isolated Perfused Rat Liver Model: Simultaneous LC-MS Quantification of Pitavastatin, Coproporphyrin I, and Coproporphyrin III Levels in the Rat Liver and Bile

  2024cites this paper
• Characterization of Elimination Pathways and the Feasibility of Endogenous Metabolites as Biomarkers of Organic Anion Transporter 1/3 Inhibition in Cynomolgus Monkeys

  2023cites this paper
• Targeting a xenobiotic transporter to ameliorate vincristine-induced sensory neuropathy

  2023cites this paper
• The Role of Coproporphyrins As Endogenous Biomarkers for Organic Anion Transporting Polypeptide 1B Inhibition–Progress from 2016 to 2023

  2023cites this paper
• Research Methods and New Advances in Drug–Drug Interactions Mediated by Renal Transporters

  2023cites this paper
• A Metabolomic Analysis of Sensitivity and Specificity of 23 Previously Proposed Biomarkers for Renal Transporter‐Mediated Drug‐Drug Interactions

  2023cites this paper
• Circulating Biomarkers Instead of Genotyping to Establish Metabolizer Phenotypes.

  2023cites this paper
• Mendelian Randomization Study of Lipid Metabolites Reveals Causal Associations with Heel Bone Mineral Density

  2023cites this paper
• Unveiling the atlas of associations between 1,400 plasma metabolites and 24 tumors: Mendelian randomization analyses

  2023cites this paper
• Effect of Cimetidine on Metformin Pharmacokinetics and Endogenous Metabolite Levels in Rats

  2023cites this paper
• The Effect of BI 730357 (Retinoic Acid‐Related Orphan Receptor Gamma t Antagonist, Bevurogant) on the Pharmacokinetics of a Transporter Probe Cocktail, Including Digoxin, Furosemide, Metformin, and Rosuvastatin: An Open‐Label, Non‐randomized, 2‐Period Fixed‐Sequence Trial in Healthy Subjects

  2023cites this paper
• N1‐Methylnicotinamide as Biomarker for MATE‐Mediated Renal Drug–Drug Interactions: Impact of Cimetidine, Rifampin, Verapamil, and Probenecid

  2023cites this paper
• Metabolomic Profiling and Drug Interaction Characterization Reveal Riboflavin As a Breast Cancer Resistance Protein–Specific Endogenous Biomarker That Demonstrates Prediction of Transporter Activity In Vivo

  2023cites this paper
• Albumin-bound kynurenic acid is an appropriate endogenous biomarker for assessment of the renal tubular OATs-MRP4 channel

  2023cites this paper
• SLCO1B1 Pharmacogenetics in Pediatrics

  2022cites this paper
• Transporters in Regulatory Science: Notable Contributions from Dr. Giacomini in the Past Two Decades

  2022cites this paper
• Reimagining the Framework Supporting the Static Analysis of Transporter Drug Interaction Risk; Integrated Use of Biomarkers to Generate Pan‐Transporter Inhibition Signatures

  2022cites this paper
• Special Section on New Era of Transporter Science: Unraveling the Functional Role of Orphan Transporters — Minireview Transporters in Regulatory Science: Notable Contributions from Dr. Giacomini in the Past Two Decades

  2022cites this paper
• Pharmacoproteomics of Brain Barrier Transporters and Substrate Design for the Brain Targeted Drug Delivery

  2022cites this paper
• Recent advances in the translation of drug metabolism and pharmacokinetics science for drug discovery and development

  2022cites this paper
• Effect of a Ketohexokinase Inhibitor (PF‐06835919) on In Vivo OATP1B Activity: Integrative Risk Assessment Using Endogenous Biomarker and a Probe Drug

  2022cites this paper
• Renal Transporter‐Mediated Drug‐Biomarker Interactions of the Endogenous Substrates Creatinine and N1‐Methylnicotinamide: A PBPK Modeling Approach

  2022cites this paper
• Endogenous Plasma Kynurenic Acid in Human: A Newly Discovered Biomarker for Drug-Drug Interactions Involving Organic Anion Transporter 1 and 3 Inhibition S

  2021cites this paper
• Transport of Drugs and Endogenous Compounds Mediated by Human OCT1: Studies in Single- and Double-Transfected Cell Models

  2021cites this paper
• Transporter-mediated drug–drug interactions: advancement in models, analytical tools, and regulatory perspective

  2021cites this paper
• Feature, Function, and Information of Drug Transporter–Related Databases

  2021cites this paper
• Endogenous Biomarkers for SLC Transporter-Mediated Drug-Drug Interaction Evaluation

  2021influential citation
• Performance of Plasma Coproporphyrin I and III as OATP1B1 Biomarkers in Humans

  2021cites this paper
• Organic Anion Transporting Polypeptide 2B1 (OATP2B1) Genetic Variants: In Vitro Functional Characterization and Association With Circulating Concentrations of Endogenous Substrates

  2021cites this paper
• Recent progress in in vivo phenotyping technologies for better prediction of transporter-mediated drug-drug interactions.

  2020cites this paper
• Detection of Weak Organic Anion – Transporting Polypeptide 1B Inhibition by Probenecid with Plasma-Based Coproporphyrin in Humans s

  2020cites this paper
• Absorption and Disposition of Coproporphyrin I (CPI) in Cynomolgus Monkeys and Mice: Pharmacokinetic Evidence to Support the Use of CPI to Inform the Potential for OATP Inhibition

  2020cites this paper
• Dose‐Dependent Inhibition of OATP1B by Rifampicin in Healthy Volunteers: Comprehensive Evaluation of Candidate Biomarkers and OATP1B Probe Drugs

  2020cites this paper
• Kidney Injury Molecule 1 in Children with Heart Failure

  2020influential citation
• Role of transporters in drug disposition and drug-drug interactions

  2020cites this paper
• Endogenous Coproporphyrin I and III Are Altered in Multidrug Resistance-Associated Protein 2-Deficient (TR-) Rats.

  2020cites this paper
• Identification of Glycochenodeoxycholate 3‐O‐Glucuronide and Glycodeoxycholate 3‐O‐Glucuronide as Highly Sensitive and Specific OATP1B1 Biomarkers

  2020cites this paper
• Innovative approaches and recent advances in the study of ontogeny of drug metabolism and transport

  2020influential citation
• Detection of Weak Organic Anion–Transporting Polypeptide 1B Inhibition by Probenecid with Plasma-Based Coproporphyrin in Humans

  2020cites this paper
• Urinary Excretion of N1-Methylnicotinamide and N1-Methyl-2-Pyridone-5-Carboxamide and Mortality in Kidney Transplant Recipients

  2020cites this paper
• Validation of a Drug Transporter Probe Cocktail Using the Prototypical Inhibitors Rifampin, Probenecid, Verapamil, and Cimetidine

  2020cites this paper
• Absorption and Disposition of Coproporphyrin I (CPI) in Cynomolgus Monkeys and Mice: Pharmacokinetic Evidence to Support the Use of CPI to Inform the Potential for Organic Anion-Transporting Polypeptide Inhibition

  2020cites this paper
• Alteration in the Plasma Concentrations of Endogenous Organic Anion–Transporting Polypeptide 1B Biomarkers in Patients with Non–Small Cell Lung Cancer Treated with Paclitaxel

  2020cites this paper
• Alteration in the plasma concentrations of endogenous OATP1B-biomarkers in non-small cell lung cancer patients treated with paclitaxel

  2020cites this paper
• Genomic determinants of hypertension with a focus on metabolomics and the gut microbiome.

  2020cites this paper
• Urinary Excretion of N1-methyl-2-pyridone-5-carboxamide and N1-methylnicotinamide in Renal Transplant Recipients and Donors

  2020cites this paper
• Clinical Aspects of Transporter‐Mediated Drug–Drug Interactions

  2019cites this paper
• LC‐MS/MS analysis of the plasma concentrations of a cocktail of 5 cytochrome P450 and P‐glycoprotein probe substrates and their metabolites using subtherapeutic doses

  2019cites this paper
• In Vitro and In Vivo Methods to Assess Pharmacokinetic Drug-Drug Interactions in Drug Discovery and Development.

  2019cites this paper
• Urinary Excretion of N1-Methylnicotinamide, as a Biomarker of Niacin Status, and Mortality in Renal Transplant Recipients

  2019cites this paper
• Clinical Studies on Drug–Drug Interactions Involving Metabolism and Transport: Methodology, Pitfalls, and Interpretation

  2019cites this paper
• Effect of Rifampicin on the Plasma Concentrations of Bile Acid-O-Sulfates in Monkeys and Human Liver-Transplanted Chimeric Mice With or Without Bile Flow Diversion.

  2019cites this paper
• Xenobiotic Transporters in the Kidney: Function and Role in Toxicity.

  2019cites this paper
• Interplay of the Organic Cation Transporters OCT1 and OCT2 with the Apically Localized Export Protein MATE1 for the Polarized Transport of Trospium.

  2019cites this paper
• Effect of OATP1B1 genotypes on plasma concentrations of endogenous OATP1B1 substrates and drugs, and their association in healthy volunteers.

  2019cites this paper
• Further Studies to Support the Use of Coproporphyrin I and III as Novel Clinical Biomarkers for Evaluating the Potential for Organic Anion Transporting Polypeptide 1B1 and OATP1B3 Inhibition

  2018cites this paper
• Title: Comprehensive evaluation of the utility of 20 endogenous molecules as biomarkers of OATP1B inhibition compared to rosuvastatin and coproporphyrin I

  2018cites this paper
• Evidence for the Validity of Pyridoxic Acid (PDA) as a Plasma-Based Endogenous Probe for OAT1 and OAT3 Function in Healthy Subjects

  2018cites this paper
• Clinical Probes and Endogenous Biomarkers as Substrates for Transporter Drug‐Drug Interaction Evaluation: Perspectives From the International Transporter Consortium

  2018cites this paper
• Comprehensive Evaluation of the Utility of 20 Endogenous Molecules as Biomarkers of OATP1B Inhibition Compared with Rosuvastatin and Coproporphyrin I

  2018cites this paper
• Importance of OCT2 and MATE1 for the Cimetidine-Metformin Interaction: Insights from Investigations of Polarized Transport in Single- And Double-Transfected MDCK Cells with a Focus on Perpetrator Disposition.

  2018cites this paper
• Contribution of multidrug and toxin extrusion protein 1 (MATE1) to renal secretion of trimethylamine-N-oxide (TMAO)

  2018cites this paper